This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEIB01YD_L.jpg
The company last year began producing an ingredient for its COVID-19 vaccine at the facility in Grange Castle, Dublin.
“This investment for non-COVID licensed and pipeline products, will help to further expand the site’s broad and robust capabilities,” Mike McDermott, chief global supply officer at Pfizer (NYSE:PFE), said.
The move will lead to the creation of 400 to 500 new roles and add a new facility, which is due for completion in 2027, according to the company.
($1 = 0.9530 euros)
